Multimorbidity increases risk of atrial fibrillation recurrence after cryoballoon ablation
- PMID: 41089336
- PMCID: PMC12516325
- DOI: 10.1016/j.ijcha.2025.101700
Multimorbidity increases risk of atrial fibrillation recurrence after cryoballoon ablation
Abstract
Background and aims: Despite advancements in atrial fibrillation (AF) catheter ablation techniques, atrial arrhythmia recurrence after the procedure remains common. Although individual comorbidities are known to affect ablation outcomes, the role of multimorbidity is unclear. This study aimed to investigate the association between multimorbidity and atrial arrhythmia recurrence after cryoballoon AF ablation.
Methods: The cryoballoon ablation study is a single-center, prospective registry including 349 consecutive patients undergoing cryoballoon AF ablation. The presence of eleven comorbidities was assessed and the population divided into two groups: no multimorbidity (0-1 comorbidity) and multimorbidity (≥2 comorbidities). Clinical follow-up visits combined with 12-lead ECG and 24-hour Holter monitoring were scheduled at 3, 6 and 12 months post-procedure. Cox proportional hazard regression analyses were conducted to assess the association with atrial arrhythmia recurrence. Kaplan-Meier estimates for the cumulative risk of the first recurrence were calculated and plotted.
Results: The mean age was 62 ± 9 years and 123 (35 %) were women. Multimorbidity was present in 184 (53 %) patients. During a median follow-up of 328 [IQR 203-409] days, 114 patients (33 %) experienced atrial arrythmia recurrence within one year after cryoballoon AF ablation. Cox proportional hazard regression analyses, adjusted for age and sex, revealed a significant association between multimorbidity (HR 1.64, 95 % CI 1.12-2.39) and atrial arrhythmia recurrence. Furthermore, hypertension (HR 1.58, 95 % CI 1.01-2.49) and obesity (HR 1.63, 95 % CI 1.09-2.42) were associated with recurrence at one year post-ablation.
Conclusion: In AF patients undergoing cryoballoon AF ablation, multimorbidity was associated with atrial arrhythmia recurrence within one year post-ablation.
Keywords: Comorbidities; Cryoballoon ablation; Multimorbidity; Recurrence.
© 2025 The Authors. Published by Elsevier B.V.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [The cryoballoon registry reports financial support was provided by Medtronic Inc. Colinda van Deutekom reports financial support was provided by Horizon Europe. Michiel Rienstra reports financial support was provided by Horizon Europe. Michiel Rienstra reports a relationship with Bayer AG that includes: consulting or advisory. Michiel Rienstra reports a relationship with InCarda Therapeutics, Inc. that includes: consulting or advisory. Michiel Rienstra reports a relationship with Netherlands Heart Foundation that includes: funding grants. Michiel Rienstra reports a relationship with ZonMW that includes: funding grants. Yuri Blaauw reports a relationship with Boston Scientific Corporation that includes: funding grants. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.].
Figures
References
-
- Lippi G., Sanchis-Gomar F., Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int. J. Stroke. 2021;16(2):217–221. - PubMed
-
- Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Europ. Heart J. 2024.
-
- Tzeis S., Gerstenfeld E.P., Kalman J., Saad E.B., Sepehri Shamloo A., Andrade J.G., et al. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. EP Europace. 2024;26(4)
-
- van Deutekom C., Hendriks J.M.L., Myrstad M., Van Gelder I.C., Rienstra M. Managing elderly patients with atrial fibrillation and multimorbidity: call for a systematic approach. Expert Rev. Cardiovasc. Ther. 2024;1–14 - PubMed
-
- Pallisgaard J.L., Gislason G.H., Hansen J., Johannessen A., Torp-Pedersen C., Rasmussen P.V., et al. Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study. Eur. Heart J. 2017;39(6):442–449. - PubMed
LinkOut - more resources
Full Text Sources
